Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea
News provided by
Share this article
Share this article
SHANGHAI and SEOUL, South Korea, March 14, 2021 /PRNewswire/ Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced the appointment of Ms. Minyoung Kim as General Manager of Antengene South Korea. Antengene is actively expanding geographic presence across APAC Markets and has established a wholly-owned subsidiary in Seoul.
Minyoung Kim
Minyoung will lead Antengene operations in South Korea and will be responsible for implementing Antengene s vision, building a talented & highly respected organization, collaborating closely with Korean healthcare professionals and commercializing Antengene s innovative portfolio of novel therapies to expand